Antinociceptive Synergism of Gabapentin and Nortriptyline in Mice with Partial Sciatic Nerve Ligation
Author
dc.contributor.author
Miranda Guzmán, Hugo
Author
dc.contributor.author
Noriega, Viviana
Author
dc.contributor.author
Zepeda Iriarte, Ramiro
Author
dc.contributor.author
Zanetta, Pilar
Author
dc.contributor.author
Prieto Rayo, Josefina
Author
dc.contributor.author
Prieto Domínguez, Juan
Author
dc.contributor.author
Sierralta, Fernando
Admission date
dc.date.accessioned
2015-08-08T20:49:40Z
Available date
dc.date.available
2015-08-08T20:49:40Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Pharmacology 2015;95:59–64
en_US
Identifier
dc.identifier.other
DOI: 10.1159/000370244
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/132512
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Background and Methods: Neuropathic pain results from nerve injury, and gabapentin, an antiepileptic drug, has been approved for the treatment of several types of neuropathic pain. On the other hand, nortriptyline, an antidepressant drug, has been suggested as an alternative treatment. In partial sciatic nerve ligation (PSNL) mice, the interaction of gabapentin with nortriptyline was evaluated by the hot plate assay using isobolographic analysis. Results: Gabapentin (3-100 mg/kg, i.p.) or nortriptyline (1-30 mg/kg, i.p.) induced dose-dependent antinociception, with an ED50 of 11.60 +/- 0.54 mg/kg for gabapentin and of 5.16 +/- 0.21 mg/kg for nortriptyline. The potency of gabapentin and nortriptyline in PSNL mice at 7 and 14 days after ligation was significantly increased (p < 0.05). Coadministration of gabapentin with nortriptyline, at a 1:1 ratio of their ED50, had a synergistic effect, with an interaction index of 0.311 and 0.348 for these mice at 7 and 14 days, respectively. Conclusion: The data showed a synergy in antinociception at a gabapentin-to-nortriptyline ratio of 1:1 in PSNL mice. This finding suggests that this combination could provide a therapeutic alternative that can be used for neuropathic pain management.